UNIQURE NV's ticker is QURE and the CUSIP is N90064101. A total of 160 filers reported holding UNIQURE NV in Q3 2023. The put-call ratio across all filers is 0.45 and the average weighting 0.1%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $165,016 | -40.7% | 24,593 | +1.4% | 0.00% | – |
Q2 2023 | $278,071 | -8.1% | 24,265 | +61.4% | 0.00% | – |
Q1 2023 | $302,707 | -10.2% | 15,030 | +1.1% | 0.00% | -100.0% |
Q4 2022 | $337,124 | +55.4% | 14,871 | +110.8% | 0.00% | – |
Q2 2021 | $217,000 | -4.0% | 7,056 | +14.8% | 0.00% | – |
Q3 2020 | $226,000 | – | 6,148 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Aquilo Capital Management, LLC | 841,471 | $15,786,000 | 5.69% |
Nantahala Capital Management | 2,901,929 | $54,440,000 | 3.52% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 544,500 | $10,209,000 | 3.27% |
683 Capital Management, LLC | 1,373,600 | $25,768,000 | 1.99% |
PFM Health Sciences, LP | 2,393,311 | $44,899,000 | 1.62% |
Integral Health Asset Management, LLC | 433,000 | $8,123,000 | 1.58% |
Privium Fund Management B.V. | 238,998 | $4,283,000 | 1.56% |
Nantahala Capital Management | 1,000,000 | $18,760,000 | 1.21% |
Henry James International Management Inc. | 89,469 | $1,678,000 | 0.94% |
Altium Capital Management LP | 105,000 | $1,970,000 | 0.72% |